Contrast-induced nephropathy in patients with type 2 diabetes during coronary angiography: Risk-factors and prognostic value

Diabetes Research and Clinical Practice

Volumn 86, Issue SUPLL.1, 2009, Pages

  Zaytseva, Natalia V ^a   Shamkhalova, Minara S ^a   Shestakova, Marina V ^a   Matskeplishvili, Simon T ^b   Tugeeva, Elvina F ^b   Buziashvili, Ury I ^b   Deev, Alexandr D ^c   Dedov, Ivan I ^a  

^a N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

^b Bakoulev Sci Ctr Cardiovasc Surg   (Russian Federation)

^c NATIONAL MEDICAL RESEARCH CENTER FOR THERAPY AND PREVENTIVE MEDICINE   (Russian Federation)

Author keywords

Contrast induced nephropathy; Coronary angiography; Diabetes mellitus; Prognostic significance; Risk factors

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN; IOHEXOL; METFORMIN; SULFONYLUREA DERIVATIVE;

ADULT; ANEMIA; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RISK FACTOR; SURVIVAL RATE;

CONTRAST MEDIA; CORONARY ANGIOGRAPHY; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME;

EID: 72049132378     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(09)70012-9     Document Type: Article

References (24)

1. European Society of Urogenital Radiology Guidelines on Contrast Media Version 5.0 ed. Available at: http://www.esur.org printed April 13, 2006.
2. Nash K., Hafeez A., and Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 39 (2002) 930-936
3. Rihal C.S., Textor S.C., Grill D.E., Berger P.B., Ting H.H., Best P.J., Singh M., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105 (2002) 2259-2264
4. Mehran R., Aymong E.D., Nikolsky E., Lasic Z., Iakovou I., Fahy M., Mintz G.S., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44 (2004) 1393-1399
5. Mehran R., and Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl (2006) S11-S15
6. Rudnick M.R., and Goldfarb S. Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality. Rev Cardiovasc Med 4 Suppl 5 (2003) S28-S33
7. Barrett B.J., and Parfrey P.S. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 354 (2006) 379-386
8. Toprak O., Cirit M., Yesil M., Byrne D.W., Postaci N., Bayata S., Majchrzak K.M., et al. Metabolic syndrome as a risk factor for contrast-induced nephropathy in non-diabetic elderly patients with renal impairment. Kidney Blood Press Res 29 (2006) 2-9
9. Pannu N., Wiebe N., and Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA 295 (2006) 2765-2779
10. Gleeson T.G., and Bulugahapitiya S. Contrast-induced nephropathy. Am J Roentgenol 183 (2004) 1673-1689
11. Goldenberg I., and Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ 172 (2005) 1461-1471
12. Rudnick M.R., Kesselheim A., and Goldfarb S. Contrast-induced nephropathy: how it develops, how to prevent it. Cleve Clin J Med 73 (2006) 75-87
13. Hashemi M., Kharazi A., and Shahidi S. Captopril for prevention of contrast induced nephropathy in patients undergoing coronary angioplasty: a double blind placebo controlled clinical trial. J Res Med Sci 10 (2005) 305-308
14. Toprak O., Cirit M., Bayata S., Yesil M., and Aslan S.L. [The effect of pre-procedural captopril on contrast-induced nephropathy in patients who underwent coronary angiography]. Anadolu Kardiyol Derg 3 (2003) 98-103
15. Cirita M., Topraka O., Yesilb M., Bayatab S., Postacib N., Pupimd L., and Esic E. Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy. Nephron Clin Pract 104 (2006) 20-27
16. Erley C.M. Does hydration prevent radiocontrast-induced acute renal failure?. Nephrol Dial Transplant 14 (1999) 1064-1066
17. Brinker J.A., Davidson C.J., and Laskey W. Preventing in-hospital cardiac and renal complications in high-risk PCI patients. Eur Heart J Suppl 7 (2005) G13-G24
18. Dangas G., Iakovou I., Nikolsky E., Aymong E.D., Mintz G.S., Kipshidze N.N., Lansky A.J., et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 95 (2005) 13-19
19. Toprak O., and Cirit M. Risk factors for contrast-induced nephropathy. Kidney Blood Press Res 29 (2006) 84-93
20. Heyman S.N., Rosenberger C., and Seymour R. Regional alterations in renal haemodynamics and oxygenation: a role in contrast medium-induced nephropathy. Nephrol Dial Transplant 20 Suppl 1 (2005) i6-i11
21. Bartholomew B.A., Harjai K.J., Dukkipati S., Boura J.A., Yerkey M.W., Glazier S., Grines C.L., et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 93 (2004) 1515-1519
22. McCullough P.A., and Soman S.S. Contrast-induced nephropathy. Crit Care Clin 21 (2005) 261-280
23. Nikolsky E., Mehran R., Lasic Z., Mintz G.S., Lansky A.J., Na Y., Pocock S., et al. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 67 (2005) 706-713
24. McCullough P.A., Wolyn R., Rocher L.L., Levin R.N., and O'Neill W.W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103 (1997) 368-375